Infectious Diseases Vaccine Market Overview
By Datamonitor
Buy Now $15,200
Publication data: 25-Oct-2010
Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price products such as Wyeth’s Prevnar or Merck & Co’s Gardasil, along with the emergence of novel vaccine technologies and favourable legislation have brought vaccines back into the main focus of pharmaceutical and biotech companies.
Scope of this research
- Market overview with current market assessment in terms of leading players, brands and geographies
- In-depth analyses of the leading 5 players’ portfolios, R&D pipelines, sales trends, geographic spread, licensing patterns and strategic outlook
- Discussion of key developments shaping the sector: new technologies, indications and geographies
- Snapshot profiles of second tier companies in the sector
Research and analysis highlights
Driven by its increasing commercial potential, the vaccines sector has been subject to significant consolidation over the last 5 years. While some of this recent activity has paved the way for newer market entrants, at the same time, established players have sought to diversify their portfolios through new acquisitions.
Key opportunities for vaccine manufacturers lie in the exploitation of novel targets with a high unmet need. Development of candidates for these indications can be facilitated by novel technologies, such as adjuvants, alternative production and delivery techniques, and novel approaches in antigen design.
Faced with limited growth prospects in the western markets, companies are increasingly turning towards emerging countries. The higher disease burden, greater medical unmet needs combined with rapid economic growth, a growing affluent middle class and private sector in these countries represents significant potential for market expansion.
Key reasons to purchase this research
- Get a comprehensive, insightful commercial overview of the vaccines market
- Learn about the strategies of the Big 5 players, their strengths, weaknesses, similarities and differences
- Gain insight into the future directions and growing strategic importance of vaccines for Big Pharma
View Table of Contents >
